Medicina
Fachbereich
Sunnybrook Health Science Centre
Toronto, CanadáPublikationen in Zusammenarbeit mit Forschern von Sunnybrook Health Science Centre (16)
2022
-
Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement
Canadian Journal of Cardiology, Vol. 38, Núm. 1, pp. 102-112
-
Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation
American Journal of Cardiology, Vol. 172, pp. 90-97
-
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 4, pp. 638-646
-
Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
Journal of the American College of Cardiology, Vol. 79, Núm. 8, pp. 772-785
2021
-
Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)
Intensive Care Medicine
-
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
Annals of Oncology, Vol. 32, Núm. 7, pp. 881-895
-
Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors
Intensive and Critical Care Nursing
-
Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study
Intensive Care Medicine, Vol. 47, Núm. 2, pp. 160-169
-
Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement
Journal of the American College of Cardiology, Vol. 77, Núm. 18, pp. 2276-2287
-
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 73, Núm. 11, pp. e3750-e3758
2020
-
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 21, Núm. 3, pp. 387-397
-
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 14, pp. 1505-1517
2018
-
Emergency Heart Failure Mortality Risk Grade score performance for 7-day mortality prediction in patients with heart failure attended at the emergency department: Validation in a Spanish cohort
European Journal of Emergency Medicine, Vol. 25, Núm. 3, pp. 169-177
-
KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes?
Annals of Oncology, Vol. 29, pp. ix164
-
Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer
New England Journal of Medicine, Vol. 378, Núm. 22, pp. 2078-2092
2017
-
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation
Journal of the American College of Cardiology, Vol. 70, Núm. 22, pp. 2752-2763